妊娠35 ~ 37周女性定植B族链球菌的血清和多位点序列分型及其相互关系

doi:10.3969/j.issn.1006-7795.2023.02.019

摘要/Abstract

摘要： 目的探讨北京某妇产医院妊娠35~37周女性生殖道和消化道定植的B族链球菌（group B streptococcus,GBS）的血清分型、多位点序列分型（multilocus sequence typing, MLST）及其之间的关系，为临床防治GBS感染以及疫苗的研制提供参考依据。方法妊娠35~37周女性常规进行阴道、直肠拭子联合采样，通过细菌培养、鉴定，分离GBS菌株，利用多重聚合酶链式反应 (polymerase chain reaction, PCR)技术及第一代测序分别进行荚膜多糖血清分型和MLST分型，并通过统计学方法分析两种分型之间的关联性。结果 147名妊娠妇女定植GBS菌，其中共发现7种血清型，前三位分别是Ⅲ型占38.7%（57/147）、Ia型占35.3%（52/147）、Ib型占19.0%（28/147），另有2株未分型（non-typeable,NT）占1.4%（2/147）；MLST分型共发现22种基因型，其中最主要的基因型是ST19占30.6%（45/147）、ST10占17.0%（25/147）、ST12占12.2%（18/147）、ST1占10.2%（15/147），另有3株菌为新发现的基因型占2.0%（3/147）；GBS菌株主要血清型（Ia、Ib、Ⅲ）和MLST的主要分型（ST1、ST10、ST12、ST19）之间关联性存在统计学意义（χ2=75.29，P<0.05)，进一步计算了Pearson列联系数C=0.6。结论本研究中,最常见3种血清型（Ⅲ型、Ⅰａ型、Ⅰｂ型）覆盖了93.2％妊娠妇女定植的GBS（137／147），GBS荚膜多糖三价结合疫苗包含上述三种血清型，提示该疫苗应用可能减少本地区围生期妇女GBS定植。ST19/Ⅲ、ST10/Ia和ST12/Ia型是妊娠妇女定植的主要序列型/血清型，为研制有针对性的GBS疫苗提供参考依据。另外，多位点序列分型中新序列型的发现补充了B族链球菌MLST数据库。

关键词: B族链球菌, 妊娠妇女, 血清分型, 多位点序列分型

Abstract: Objective To discuss the serotyping, multilocus sequence typing (MLST) of group B streptococcus (GBS) colonized in reproductive tract of women at 35－37 weeks gestation in an Obstetrics and Gynecology Hospital of Beijing, and to provide reference for clinical prevention and treatment of GBS infection and research and development of vaccines. Methods Women at 35－37 weeks of gestation were routinely sampled with vaginal and rectal swabs. GBS strains were cultured, identified and isolated. Capsular polysaccharide serotyping and MLST typing were performed by multiplex polymerase chain reaction (PCR) and first generation sequencing， respectively, and the correlation between the two types was analyzed by statistical method. Results GBS strains were colonized in 147 pregnant women, of which 7 serotypes were found. The first three strains were 38.7% (57/147) of type Ⅲ, 35.3% (52/147) of type Ia, 19.0% (28/147) of type Ib, and 1.4% (2/147) of non-typable (NT) strains. Twenty-two genotypes were found in MLST genotypes. The popular genotypes were ST19 30.6% (45/147), ST10 17.0% (25/147), ST12 12.2% (18/147), ST1 10.2% (15/147) and 3 new genotypes 2.0% (3/147). The correlation between the main serotypes of GBS (Ia, Ib, Ⅲ) and the main types of MLST (ST19, ST10, ST12, ST1) was statistically significant (χ2 =75.29,P< 0.05).The Pearson contingency coefficient was calculated further, C=0.6. Conclusion In this study, the three most common serotypes (Ⅲ,Ia and Ib) covered 93.2% of GBS colonized in pregnant women (137/147), and GBS capsular polysaccharide protein conjugate vaccines contained the above three serotypes, suggesting that the application of this vaccine may reduce GBS infection in perinatal women in this area. ST19/Ⅲ, ST10/Ia and ST12/Ia types are the main sequence types/serotypes that colonize pregnant women, which provide reference for developing targeted GBS vaccines.In addition, the discovery of new sequences in multilocus sequence typing supplements the MLST database of group B streptococcus.

Key words: This study was supported by group B streptococcus (GBS), pregnant women, serotyping, multilocus sequence typingB

中图分类号:

R446

刘晶, 董媛, 吉彤珍. 妊娠35 ~ 37周女性定植B族链球菌的血清和多位点序列分型及其相互关系[J]. 首都医科大学学报, 2023, 44(2): 311-315.

Liu Jing, Dong Yuan, Ji Tongzhen. Serum and multilocus sequence typing of group B streptococcus colonized in women at 35－37 weeks of pregnancy and their relationship[J]. Journal of Capital Medical University, 2023, 44(2): 311-315.

参考文献

［1］Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology［J］. Front Microbiol, 2018, 9(437):1－14.
［2］Khatami A, Randis T M, Tavares L, et al. Vaginal co-colonization with multiple group B streptococcus serotypes［J］. Vaccine. 2019, 37(3):409－411.
［3］Bobadilla F J, Novosak M G, Cortese I J, et al. Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35－37 weeks of gestation［J］. BMC Infect Dis, 2021, 21(1):73.
［4］赵晶,刘静娴,刘瑛.无乳链球菌分子流行病学研究进展［J］.中国感染与化疗杂志, 2021, 21（4）:489－494.
［5］Verani J R，Mcgee L，Schrag S J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC，2010［J］. MMWR Recomm Rep, 2010, 59（RR－10）:1－36.
［6］孙振球.医学统计学［M］.北京：人民卫生出版社，2002：112－113.
［7］Ali M M, Woldeamanuel Y, Woldetsadik D A, et al. Prevalence of group B streptococcus among pregnant women and newborns at Hawassa University comprehensive specialized hospital, Hawassa, Ethiopia［J］. BMC Infect Dis, 2019，19(1):325.
［8］王莹, 何佩, 陈莉, 等.孕晚期生殖道B族链球菌感染的影响因素分析［J］.中华医院感染学杂志,2019，29（17):2700－2704.
［9］Safari D, Gultom S M, Tafroji W, et al. Prevalence, serotype and antibiotic susceptibility of group B streptococcus isolated from pregnant women in Jakarta, Indonesia［J］. PLoS One. 2021,16(5):e0252328.
［10］Furfaro L L, Nathan E A, Chang B J, et al. Group B streptococcus prevalence, serotype distribution and colonization dynamics in Western Australian pregnant women［J］. J Med Microbiol, 2019,68(5):728－740.
［11］郑美玲,李俊,邱辉,等.妊娠合并B族链球菌感染相关因素调查［J］.中国病原生物学杂志,2022,17(6):682－684，688.
［12］解安霞,李惠琴,刘占梅.452例妊娠晚期孕妇B族链球菌感染及妊娠结局调查和定植高危因素分析［J］.中国病原生物学杂志,2020,15(8):967－970.
［13］陈华, 俞萍, 张吉平, 等. 围生期妇女生殖道感染B族链球菌耐药基因及毒力基因分析［J］. 中华医院感染学杂志, 2021, 31(12):1916－1920.
［14］李东, 张树琛, 时琰丽, 等. 北京地区孕晚期妇女定植B族链球菌耐药状况与血清型分布情况分析［J］. 首都医科大学学报,2018,39(4):591－595.
［15］林雅茵，林新祝，郑欣怡，等.B族链球菌血清型和基因型及耐药性的研究［J］.中华医院感染学杂志, 2020, 30（9）:1292－1296.
［16］Russell N J, Seale A C, ODriscoll M, et al. Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses［J］. Clin Infect Dis, 2017,65(Suppl 2):S100－S111.
［17］殷晓辰, 林雅华.B族链球菌疫苗研究现状及展望［J］.中国生物制品学杂志，2018, 31（11）:1274－1278，1282。
［18］Baker C J, Rench M A, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine［J］. Vaccine, 2003,21(24):3468－3472.
［19］郭丹, 曹雪莲, 温国明, 等.深圳孕妇定植B族链球菌的分子分型研究［J］.广东医学, 2017, 38（22）:3463－3465.
［20］Lee H T, Kim S Y, Park P W, et al. Detection and genomic analysis of genital group B streptococcus in pregnant Korean women［J］. J Obstet Gynaecol Res, 2019,45(1):69－77.
［21］Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women［J］. J Clin Microbiol, 2017, 55(2):412－422.
［22］Gao K K, Gao C Y, Huang L F，et al. Predominance of III/ST19 and Ib/ST10 lineages with high multidrug resistance in fluoroquinolone-resistant group B streptococc isolates in which a new integrative and conjugative element was identified［J］. Front Microbiol, 2021,11:609526.
［23］中华医学会围产医学分会,中华医学会妇产科学分会产科学组.预防围产期B族链球菌病(中国)专家共识［J］.中华围产医学杂志,2021,24(8):561－566.
［24］高坎坎,钟华敏,梁绮华,等. B族链球菌相关疫苗的研究进展［J］.中华妇幼临床医学杂志(电子版),2017,13(1):116－119.

[1]	李榕, 陈静, 李传云, 周童, 陈欢, 陈德喜, 乔跃兵, 李伟华. 过滤对超速离心法提取外泌体的影响[J]. 首都医科大学学报, 2021, 42(6): 1007-1013.
[2]	尉景娟, 马立艳, 苏建荣. 替加环素与5种抗菌药物对耐左氧氟沙星嗜麦芽窄食单胞菌的体外药敏试验及联合药敏试验[J]. 首都医科大学学报, 2021, 42(4): 623-628.
[3]	李雪, 石中月, 杨志明, 庞文博, 金木兰. 人工智能辅助分析在宫颈液基薄层细胞学检查中的应用价值[J]. 首都医科大学学报, 2020, 41(3): 360-363.
[4]	梅曼, 任添华. 静脉血和动脉血气电解质、血红蛋白浓度的相关性研究[J]. 首都医科大学学报, 2020, 41(2): 267-271.
[5]	乔莉, 曹洋, 袁宏勋, 王瑶. ICU中心静脉导管相关性血流感染的危险因素及病原菌分析[J]. 首都医科大学学报, 2020, 41(1): 125-130.
[6]	王蕤, 吴素萍, 徐品颖. 血浆miRNA-320C和miRNA-6088对Ⅱ型糖尿病肾病的诊断价值[J]. 首都医科大学学报, 2019, 40(3): 466-472.
[7]	李东, 张树琛, 时琰丽, 李雪清, 鲁炳怀. 北京地区孕晚期妇女定植B族链球菌耐药状况与血清型分布情况分析[J]. 首都医科大学学报, 2018, 39(4): 591-595.
[8]	刘竞争, 郑光辉, 吕虹, 陈燕, 马瑞敏, 张国军. “ESKAPE”在神经外科医源性感染的流行病学研究[J]. 首都医科大学学报, 2017, 38(4): 530-534.
[9]	白晶, 张立军, 展玉涛, 郭多, 刘向祎. 化学发光酶免疫法检测血清GP73的临床应用[J]. 首都医科大学学报, 2017, 38(4): 566-571.
[10]	张树琛, 王杉, 朱凤霞, 时琰丽, 李东, 鲁炳怀. B群链球菌显色培养基在孕产妇B群链球菌筛查中的性能评价[J]. 首都医科大学学报, 2016, 37(5): 680-683.
[11]	杨品娜, 刘刚, 田敬华. 煤工尘肺合并慢性阻塞性肺疾病患者痰培养细菌耐药情况分析[J]. 首都医科大学学报, 2016, 37(4): 486-490.
[12]	吕虹, 吴渊, 王利娟, 张国军. 抗神经元抗体对神经系统副肿瘤综合征诊断的意义[J]. 首都医科大学学报, 2016, 37(4): 491-494.
[13]	方芳, 陈柯霖, 陈燕, 黄泽玉, 吕虹, 刘淑静, 周金, 张国军, 康熙雄. 应用CNAS CL-36标准评估HBV DNA定量检测试剂的抗干扰能力[J]. 首都医科大学学报, 2016, 37(4): 495-499.
[14]	刘相佟, 陶丽新, 杨昆, 李海彬, 郭晋, 郭秀花. 血红蛋白与成人代谢综合征及其组分关联性的五年队列研究[J]. 首都医科大学学报, 2016, 37(4): 509-512.
[15]	王克迪, 苏建荣. 化学发光微粒子免疫检测法筛查梅毒的结果分析[J]. 首都医科大学学报, 2016, 37(4): 519-522.